Bradford Dahms
President at THESEUS PHARMACEUTICALS, INC.
Profile
Bradford D.
Dahms is currently the President, Chief Financial & Accounting Officer at Theseus Pharmaceuticals, Inc. He previously worked as a Senior VP-Healthcare Investment Banking at Cantor Fitzgerald & Co. from 2014 to 2019.
Before that, he was an Analyst at JPMorgan Chase & Co. from 2010 to 2012.
Bradford also served as the Chief Financial & Accounting Officer at Selecta Biosciences, Inc. from 2019 to 2021.
He obtained his undergraduate degree from The Ohio State University.
Bradford Dahms active positions
| Companies | Position | Start |
|---|---|---|
| THESEUS PHARMACEUTICALS, INC. | President | 2023-12-06 |
Former positions of Bradford Dahms
| Companies | Position | End |
|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | Director of Finance/CFO | 2021-05-20 |
Cantor Fitzgerald & Co.
 Cantor Fitzgerald & Co. Investment Banks/BrokersFinance Cantor Fitzgerald & Co. is the investment bank and brokerage subsidiary of CFS CF & Co. I Holdings LP, which is owned by Cantor Fitzgerald LP in the US. The firm was founded by Bernie Gerald Cantor and John Fitzgerald in 1945. Headquartered in New York City, Cantor Fitzgerald offers clients a global, multi-asset prime brokerage platform with a focus on the quality middle market. | Corporate Officer/Principal | 2019-07-31 |
| JPMORGAN CHASE & CO. | Corporate Officer/Principal | 2011-12-31 |
Training of Bradford Dahms
| The Ohio State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| JPMORGAN CHASE & CO. | Finance |
| Private companies | 3 |
|---|---|
Cantor Fitzgerald & Co.
Cantor Fitzgerald & Co. Investment Banks/BrokersFinance Cantor Fitzgerald & Co. is the investment bank and brokerage subsidiary of CFS CF & Co. I Holdings LP, which is owned by Cantor Fitzgerald LP in the US. The firm was founded by Bernie Gerald Cantor and John Fitzgerald in 1945. Headquartered in New York City, Cantor Fitzgerald offers clients a global, multi-asset prime brokerage platform with a focus on the quality middle market. | Finance |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
Theseus Pharmaceuticals, Inc.
 Theseus Pharmaceuticals, Inc. BiotechnologyHealth Technology Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. The company was founded by William C. Shakespeare, David C. Dalgarno, Iain D. Dukes, Wei Sheng Huang and Victor M. Rivera on December 29, 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Bradford Dahms